Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,467.65
(
0.19%
)
News Focus
News Focus
Post# of 257300
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lgonber

Send PM Follow Ignore
Followers 12
Posts 648
Boards Moderated 0
Alias Born 12/20/2014

lgonber

Re: DewDiligence post# 196270

Friday, 10/23/2015 7:34:51 AM

Friday, October 23, 2015 7:34:51 AM

Post# of 257300
Good post.COngrats for you purchase at $20. As an investor in GILD and ACHN, yesterday´s news favored my portfolio. I am considering a purchase in ENTA in case it goes back to the levels you bought. My only concern is if doctors are reluctant to prescribe V-pack to all cirrhotic patients (just in case) which is about 25% of patients with hepatitis C. DO you think this could happen? and if so, would that impact in ENTA royalties significantly?
thank you
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today